JLens 500 Jewish Advocacy U.S. ETF (NYSEARCA:TOV – Get Free Report) was the recipient of a significant decrease in short interest during the month of June. As of June 15th, there was short interest totaling 1,782 shares, a decrease of 64.1% from the May 31st total of 4,970 shares. Based on an average daily trading volume, of 1,940 shares, the days-to-cover ratio is currently 0.9 days. Currently, 0.0% of the company’s stock are short sold.
JLens 500 Jewish Advocacy U.S. ETF Stock Performance
Shares of TOV traded up $0.31 on Tuesday, hitting $31.51. 3,773 shares of the stock traded hands, compared to its average volume of 13,103. JLens 500 Jewish Advocacy U.S. ETF has a one year low of $25.98 and a one year high of $32.04. The company has a market capitalization of $237.27 million, a PE ratio of 25.69 and a beta of 1.03. The business has a 50 day simple moving average of $31.04 and a 200 day simple moving average of $29.47.
Institutional Trading of JLens 500 Jewish Advocacy U.S. ETF
Several institutional investors have recently added to or reduced their stakes in TOV. Captrust Financial Advisors bought a new stake in shares of JLens 500 Jewish Advocacy U.S. ETF in the 2nd quarter worth $6,038,000. JPMorgan Chase & Co. bought a new position in shares of JLens 500 Jewish Advocacy U.S. ETF during the third quarter valued at $25,000. Finally, Bank of New York Mellon Corp lifted its holdings in shares of JLens 500 Jewish Advocacy U.S. ETF by 66.7% during the first quarter. Bank of New York Mellon Corp now owns 71,189 shares of the company’s stock valued at $1,946,000 after purchasing an additional 28,496 shares in the last quarter.
JLens 500 Jewish Advocacy U.S. ETF Company Profile
The JLens 500 Jewish Advocacy U.S. ETF (TOV) is an exchange-traded fund that is based on the JLens 500 Jewish Advocacy U.S. index. The fund tracks an index of large-cap US stocks while employing a methodology that seeks to align stock selection and weighting with Jewish value pillars. TOV was launched on Feb 26, 2025 and is issued by JLens.
Recommended Stories
- Five stocks we like better than JLens 500 Jewish Advocacy U.S. ETF
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
- AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
Receive News & Ratings for JLens 500 Jewish Advocacy U.S. ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JLens 500 Jewish Advocacy U.S. ETF and related companies with MarketBeat.com's FREE daily email newsletter.
